Expert answers

Treatments and drugs

Dec. 22, 2015
  1. AskMayoExpert. Granulomatosis with polyangiitis. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
  2. Granulomatosis with polyangiitis (Wegener's). American College of Rheumatology Accessed Oct. 6, 2015.
  3. Ferri FF. Granulomatosis with polyangiitis (Wegener's granulomatosis). In: Ferri's Clinical Advisor 2016. Philadelphia, Pa.: Mosby Elsevier; 2016. Accessed Oct. 6, 2015.
  4. Guillevin L, et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. New England Journal of Medicine. 2014;371:1771.
  5. Longo DL, et al., eds. The vasculitis syndromes. In: Harrison's Principles of Internal Medicine. 19th ed. New York, N.Y.: McGraw-Hill Education; 2015. Accessed Oct. 6, 2015.
  6. Langford CA. Update on the treatment of granulomatosis with polyangiitis (Wegener's). Current Treatment Options in Cardiovascular Medicine. 2012;14:164.
  7. Gwathmey KG, et al. Vasculitic neuropathies. Lancet Neurology. 2014;13:67.
  8. Zand L, et al. Treatment of ANCA-associated vasculitis: New therapies and a look at old entities. Advances in Chronic Kidney Disease. 2014;21:182.
  9. Holle JU, et al. Clinical manifestations and treatment of Wegener's granulomatosis. Rheumatologic Disease Clinics of North America. 2010;36:507.
  10. Clain JM, et al. Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis. Therapeutic Advances in Musculoskeletal Disease. 2014;6:58.
  11. Trimarchi Mt, et al. Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener's). Autoimmunity Reviews. 2013;12:501.
  12. Springer J, et al. Granulomatosis with polyangiitis (Wegener's): Impact of maintenance therapy duration. Medicine. 2014;93:82.